Skip navigation

Vaccine Production:

Potential Engineering Approaches to a Pandemic

Home :: Speakers :: Phillip Green

Conference Speaker

Phillip Green, Ph.D.
Senior Scientist
The Procter & Gamble Company

Phillip Green received his B.A. from Knox College in 1978 majoring in biology and chemistry. He received his Ph.D. in biochemistry from Duke University in 1984. His thesis research was on the enzymology of membrane phospholipid biosynthesis in E. coli. Dr. Green was a postdoctoral fellow in the Department of Biology at The California Institute of Technology from 1984 - 1987 studying the enzymology of tRNA processing in Saccharomyces cerevisiae. He joined the corporate biotechnology group at Procter & Gamble in 1987 as a protein chemist/enzymologist working on protein purification and enzyme engineering. In 1989, he began to explore the application of agricultural biotechnology to materials of interest to P&G, such as the development by Calgene of the first domestic high lauric acid Canola crop and the use of crops to produce polyhydroxyalkanoate (PHA) polymers for consumer goods use. Dr. Green transferred to P&G Chemicals in 2000 to develop bioprocesses and materials produced from alternative feedstocks, and worked with Kaneka Corporation in the development of a fermentation process for the production of Nodax™ PHA.

Vaccine Production: Potential Engineering Approaches to a Pandemic
April 10-11, 2006

If you can read this message you probably are using a browser that is out dated.
Your internet browsing experience will improve by simply upgrading your browser
to the current version.